Received: 11 August 2020
Accepted: 16 September 2020
First Online: 3 November 2020
Ethics approval and consent to participate
: The present survey did not require ethics committees’ approval as no health intervention had been administered to participants (Italian law Decreto 8 febbraio 2013 n. 34).The research was conducted by Doxa Pharma S.r.l. in compliance with the General Data Protection Regulation (EU) 2016/679 (GDPR) and in line with well-established regulatory practices/procedures governing marketing research, including the Market Research Society (MRS) code of conduct (2019 revision) and the Italian Code of Professional Ethics (ASSIRM, 2016 revision).Physicians actively chose to participate to the survey and signed the following documents: data retention policy, data privacy statement, and data processing agreement. The interview questions were not aimed at investigating sensitive issues like religious or political beliefs or sexual orientation. Doxa Pharma S.r.l ensured pseudonymization of individual answers before primary data abstraction and analysis.
: All the authors gave consent to publication of the manuscript and, in case of its acceptance, the copyright is transferred to Clinical and Molecular Allergy.
: The authors declare that they have no competing interests.